Real-time enrollment status for this alzheimer's disease clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:24 AM UTC
| NCT Number | NCT07094516 |
| Recruiting Status | Recruiting |
| Condition | Alzheimer's Disease |
| Phase | PHASE2 |
| Target Enrollment | 407 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | June 26, 2026 (Jun 26, 2026) |
As of August 28, 2026: Clinical trial NCT07094516 is currently recruiting participants. This phase2 study for alzheimer's disease is actively seeking new participants at 24 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07094516 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07094516 was last updated Jun 26, 2026 (June 26, 2026). HelloStudys verifies this status automatically.